Stock Events

Stock Events

Cytokinetics (CYTK) Q2 2024 Earnings

8MayConfirmed

Q3 2023

Q4 2023

Q1 2024

Q2 2024

-1.38

-1.17

-0.97

-0.76

Details

Expected EPS

-1.143663

Actual EPS

-1.33

Surprise EPS

-0.19

Surprise Percent

+16.29%

Description

Cytokinetics (CYTK) has reported earnings of -1.33 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.